课题基金 / 基金详情

项目摘要

项目成果

Peter JOHN HART的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The oxidative decarboxylation of isocitrate to alpha-ketoglutarate catalyzed by mitochondrial NAD-specific isocitrate dehydrogenases is a rate limiting step in the tricarboxylic acid (TCA) cycle. The affinity of the yeast enzyme (IDH) for isocitrate is allosterically regulated, positively by AMP and negatively by ATP and NADH. This allosteric control has been proposed to contribute to inverse regulation of rates of energy production by oxidative pathways and by glycolysis. Thus, under conditions of energy sufficiency, i.e. when relative cellular ratios of [ATP]/[AMP] and of [NADH]/[NAD] are high, flux through the TCA cycle would be attenuated at the level of IDH, rates of glycolysis would increase, and the tricarboxylic acids, citrate and isocitrate, would be diverted into biosynthetic pathways. Yeast IDH is an octamer composed of four IDH1 and four IDH2 subunits. IDH1 (M.W. = 38,001) and IDH2 (M.W. = 37,755) share 42% sequence identity. Results of targeted mutagenesis studies suggest that the IDH2 subunit contains catalytic isocitrate/Mg2+ and NAD binding sites, whereas homologous sites in the IDH1 subunit function in cooperative binding of isocitrate and in binding of the allosteric activator AMP. An understanding of the oligomeric structure of IDH would thus illuminate relationships between homologous catalytic and regulatory ligand binding sites. We have produced crystals of IDH that diffract to 3.2¿¿¿ on a Rigaku FR-D rotating anode X-ray source. We anticipate that the determination of the oligomeric arrangement of IDH in the crystal structure will reveal the mode of allosteric control of this complex enzyme. Additionally, the information provided by the structure will direct future experiments investigating IDH enzymology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Structure-guided redesign of an antischistosomal drug
The Intron Debranching Enzyme (Dbr1) in Amyotrophic Lateral Sclerosis
Structure and action of CARDS toxin
MOUSE SOD1 AND HUMAN/MOUSE SOD1 CHIMERAS
  • 批准号:
    8361708
  • 项目类别:
  • 资助金额:
    $1.1万
  • 财政年份:
    2011
  • 负责人:
    Peter JOHN HART
  • 依托单位:
海外基金